High levels of survivin expression are independent risk factors for poor prognosis in several cancers and the cytoplasmic localization of survivin is particularly high in prostate tumors [68], whereas increased nuclear expression of survivin is a favorable prognostic factor [68]. Here, BIRC5 is linked to cancer.